A citation-based method for searching scientific literature


List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.
Haitham W Tuffaha, Andrew Mitchell, Robyn L Ward, Luke Connelly, James R G Butler, Sarah Norris, Paul A Scuffham. Genet Med 2018
35
66

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Veda N Giri, Karen E Knudsen, William K Kelly, Wassim Abida, Gerald L Andriole, Chris H Bangma, Justin E Bekelman, Mitchell C Benson, Amie Blanco, Arthur Burnett,[...]. J Clin Oncol 2018
99
33

Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
Heather Cheng, Jacquelyn Powers, Kerry Schaffer, Oliver Sartor. Am Soc Clin Oncol Educ Book 2018
14
33

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
Hong Truong, Sarah E Hegarty, Leonard G Gomella, William K Kelly, Edouard J Trabulsi, Costas D Lallas, Veda N Giri. J Genet Couns 2017
8
33

Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.
Ranjit Manchanda, Oleg Blyuss, Faiza Gaba, Vladimir Sergeevich Gordeev, Chris Jacobs, Matthew Burnell, Carmen Gan, Rohan Taylor, Clare Turnbull, Rosa Legood,[...]. J Med Genet 2018
21
33

Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Kevin A Nguyen, Jamil S Syed, Carin R Espenschied, Holly LaDuca, Ansh M Bhagat, Alfredo Suarez-Sarmiento, Timothy K O'Rourke, Karina L Brierley, Erin W Hofstatter, Brian Shuch. Cancer 2017
23
33

Cancer risk management decision making for BRCA+ women.
Terri Jabaley Leonarczyk, Barbara E Mawn. West J Nurs Res 2015
11
33


Genetic testing for hereditary prostate cancer: Current status and limitations.
Jun Tu Zhen, Jamil Syed, Kevin Anh Nguyen, Michael S Leapman, Neeraj Agarwal, Karina Brierley, Xavier Llor, Erin Hofstatter, Brian Shuch. Cancer 2018
32
33



Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
Veda N Giri, Sarah E Hegarty, Colette Hyatt, Erin O'Leary, John Garcia, Karen E Knudsen, William K Kelly, Leonard G Gomella. Prostate 2019
31
33

Familial communication and cascade testing among relatives of BRCA population screening participants.
Sari Lieberman, Amnon Lahad, Ariela Tomer, Sivan Koka, Malka BenUziyahu, Aviad Raz, Ephrat Levy-Lahad. Genet Med 2018
29
33

Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
Veda N Giri, Elias Obeid, Sarah E Hegarty, Laura Gross, Lisa Bealin, Colette Hyatt, Carolyn Y Fang, Amy Leader. Prostate 2018
9
33

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
49
33

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
133
33

The family medical history.
Robin L Bennett. Prim Care 2004
26
33

Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue.
Wendy S Rubinstein, Hongmei Jiang, Lisa Dellefave, Alfred W Rademaker. Genet Med 2009
36
33

Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
Dirk Müller, Marion Danner, Kerstin Rhiem, Björn Stollenwerk, Christoph Engel, Linda Rasche, Lisa Borsi, Rita Schmutzler, Stephanie Stock. Eur J Health Econ 2018
21
33

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Usha Menon, Alistair J McGuire, Maria Raikou, Andy Ryan, Susan K Davies, Matthew Burnell, Aleksandra Gentry-Maharaj, Jatinderpal K Kalsi, Naveena Singh, Nazar N Amso,[...]. Br J Cancer 2017
13
33

Discounting in Economic Evaluations.
Arthur E Attema, Werner B F Brouwer, Karl Claxton. Pharmacoeconomics 2018
103
33

Ovarian Cancer Prevention and Screening.
Usha Menon, Chloe Karpinskyj, Aleksandra Gentry-Maharaj. Obstet Gynecol 2018
54
33

Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Lauren A Cadish, Jonathan P Shepherd, Emma L Barber, Beri Ridgeway. Am J Obstet Gynecol 2017
26
33

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
849
33

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
121
33

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder. Int J Technol Assess Health Care 2013
168
33



Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Sarah E Dilley, Laura J Havrilesky, Jamie Bakkum-Gamez, David E Cohn, J Michael Straughn, Aaron B Caughey, Maria I Rodriguez. Gynecol Oncol 2017
27
33

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
193
33

Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation.
Ben Kearns, Jim Chilcott, Sophie Whyte, Louise Preston, Susi Sadler. BMC Med 2016
15
33

Beware of Kinked Frontiers: A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening.
James F O'Mahony, Steffie K Naber, Charles Normand, Linda Sharp, John J O'Leary, Inge M C M de Kok. Value Health 2015
10
33



Cost-effectiveness analysis of a low-fat diet in the prevention of breast and ovarian cancer.
Antônio M Bós, Barbara V Howard, Shirley A A Beresford, Nicole Urban, Lesley F Tinker, Hugh Waters, Angelo J Bós, Rowan Chlebowski, Jacqueline M Ennis. J Am Diet Assoc 2011
9
33

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
V R Grann, K S Panageas, W Whang, K H Antman, A I Neugut. J Clin Oncol 1998
163
33

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
100
33

Cost-effectiveness of Ovarian Cancer Prevention Strategies.
Janice S Kwon. Clin Obstet Gynecol 2017
2
50

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Li Sun, Adam Brentnall, Shreeya Patel, Diana S M Buist, Erin J A Bowles, D Gareth R Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey,[...]. JAMA Oncol 2019
40
33

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
491
33

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Victor R Grann, Priya R Patel, Judith S Jacobson, Ellen Warner, Daniel F Heitjan, Maxine Ashby-Thompson, Dawn L Hershman, Alfred I Neugut. Breast Cancer Res Treat 2011
69
33

The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer.
R W Melissa Tai, Stephanie K Y Choi, Peter C Coyte. J Obstet Gynaecol Can 2018
8
33

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder. Value Health 2013
308
33

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013
103
33


A review of cost-effectiveness studies in ovarian cancer.
Gregory P Sfakianos, Laura J Havrilesky. Cancer Control 2011
23
33

Systematic overview of cost-effectiveness thresholds in ten countries across four continents.
Ruth Schwarzer, Ursula Rochau, Kim Saverno, Beate Jahn, Bernhard Bornschein, Nikolai Muehlberger, Magdalena Flatscher-Thoeni, Petra Schnell-Inderst, Gaby Sroczynski, Martina Lackner,[...]. J Comp Eff Res 2015
57
33


Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
Janice S Kwon, Charlotte C Sun, Susan K Peterson, Kristin G White, Molly S Daniels, Stephanie G Boyd-Rogers, Karen H Lu. Cancer 2008
63
33

Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
Martin Widschwendter, Allison Jones, Iona Evans, Daniel Reisel, Joakim Dillner, Karin Sundström, Ewout W Steyerberg, Yvonne Vergouwe, Odette Wegwarth, Felix G Rebitschek,[...]. Nat Rev Clin Oncol 2018
60
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.